Prolonged Q-Tc interval in mild portal hypertensive cirrhosis

Journal of Hepatology

Volumn 43, Issue 4, 2005, Pages 637-644

  Ytting, Henriette ^a   Henriksen, Jens H ^a   Fuglsang, Stefan ^a   Bendtsen, Flemming ^a   Møller, Søren ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bazett correction; Cirrhotic cardiomyopathy; Hyperdynamic circulation; Liver dysfunction; Q T interval; Repolarisation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HEART REPOLARIZATION; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; QT PROLONGATION;

ADULT; ARRHYTHMIA; BLOOD PRESSURE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LONG QT SYNDROME; MALE; MIDDLE AGED; VASCULAR RESISTANCE;

EID: 24344470147     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.04.015     Document Type: Article

References (35)

1. R.J. Groszmann Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences Hepatology 20 1994 1359 1363
2. J.H. Henriksen, S. Fuglsang, F. Bendtsen, E. Christensen, and S. Møller Arterial compliance in patients with cirrhosis Am J Physiol 280 2001 584 594
3. V. Andreu, A. Perello, E. Moitinho, A. Escorsell, J.C. Garcia-Pagan, and J. Bosch Total effective vascular compliance in patients with cirrhosis. Effects of propranolol J Hepatol 36 2002 356 361
4. R. de Franchis, and M. Primignani Natural history of portal hypertension in patients with cirrhosis Clin Liver Dis 5 2001 645 663
5. J.G. Abraldes, I. Tarantino, J. Turnes, J.C. Garcia-Pagan, J. Rodes, and J. Bosch Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis Hepatology 37 2003 902 908
6. F. Feu, J.C. Garcia-Pagan, J. Bosch, A. Luca, J. Teres, and A. Escorsell Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis Lancet 346 1995 1056 1059
7. J. Vorobioff, R.J. Groszmann, E. Picabea, M. Gamen, R. Villavicencio, and J. Bordato Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study Gastroenterology 11 1996 701 709
8. U. Tage-Jensen, J.H. Henriksen, E. Christensen, A. Widding, H. Ring-Larsen, and N.J. Christensen Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis J Hepatol 6 1988 350 358
9. S. Møller, F. Bendtsen, E. Christensen, and J.H. Henriksen Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding J Hepatol 21 1994 940 946
10. J. Llach, P. Ginés, V. Arroyo, A. Rimola, L. Tito, and S. Badalamenti Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites Gastroenterology 94 1988 482 487
11. A. Braillon, R. Moreau, A. Hadenque, D. Roulot, R. Sayegh, and D. Lebrec Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol J Hepatol 9 1989 312 318
12. M. Bernardi, S. Clandra, A. Colantoni, F. Trevisani, M.L. Raimondo, and G. Sica QT interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors Hepatology 27 1998 28 34
13. H.Q. Liu, and S.S. Lee Cardiopulmonary dysfunction in cirrhosis J Gastroenterol Hepatol 14 1999 600 608
14. S. Møller, and J.H. Henriksen Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease Heart 87 2002 9 15
15. C.P. Day, O.F. James, T.J. Butler, and R.W. Campbell QT prolongation and sudden cardiac death in patients with alcoholic liver disease Lancet 341 1993 1423 1428
16. R. Mohamed, P.R. Forsey, M.K. Davies, and J.M. Neuberger Effect of liver transplantation on Q-T interval prolongation and autonomic dysfunction in end-stage liver disease Hepatology 23 1996 1128 1134
17. P. Gentilini, R.G. Romanelli, G. Laffi, G. Barletta, R. Del Bene, and G. Messeri Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture J Hepatol 30 1999 632 638
18. J.H. Henriksen, S. Fuglsang, F. Bendtsen, E. Christensen, and S. Møller Dyssynchronous electrical and mechanical systole in patients with cirrhosis J Hepatol 36 2002 513 520
19. F. Trevisani, M. Merli, F. Savelli, V. Valeriano, A. Zambruni, and O. Riggio QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt J Hepatol 38 2003 461 467
20. c) in patients with cirrhosis J Hepatol 40 2004 239 246
21. c-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man J Hepatol 4 1987 66 70
22. J.H. Henriksen, F. Bendtsen, T.I.A. Sørensen, C. Stadeager, and H. Ring-Larsen Reduced central blood volume in cirrhosis Gastroenterology 97 1989 1506 1513
23. S. Møller, N. Wiinberg, and J.H. Henriksen Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis Hepatology 22 1995 88 95
24. N. Tygstrup Determination of the hepatic galactose elimination capacity after a single intravenous injection in man Acta Physiol Scand 58 1963 162 172
25. c interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes Scand J Clin Lab Invest 60 2000 323 332
26. H.C. Bazett An analysis of the time-relations of electrocardiograms Heart 7 1920 353 370
27. P.E. Puddu, R. Jouve, S. Mariotti, S. Giampaoli, M. Lanti, and A. Reale Evaluation of 10 QT prediction formulas in 881 middleaged men from the seven countries study: emphasis on the cubic root Fridericia's equation J Electrocardiol 21 1988 219 229
28. M. Garcia Gonzalez, A. Hernandez-Madrid, A. Lopez-Sanroman, A. Candela, J. Nuno, and R. Barcena Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation Transplant Proc 31 1999 2366 2367
29. c interval: relationship with etiology and severity of liver disease, mortality and liver transplantation Liver Int 23 2003 243 248
30. B. Attali Ion channels. A new wave for heart rhythms Nature 384 1996 24 25
31. J. Kiehn, A.E. Lacerda, B. Wible, and A.M. Brown Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide Circulation 94 1996 2572 2579
32. H.J. Witchel, and J.C. Hancox Familial and acquired long QT syndrome and the cardiac rapid delayed rectifier potassium current Clin Exp Pharmacol Physiol 10 2000 753 766
33. E. Ficker, D. Thomas, P.C. Viswanathan, A.T. Dennis, S.G. Priori, and C. Napolitano Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome Am J Physiol Heart Circ Physiol 4 2000 H1748 H1756
34. J.H. Zavecz, O. Bueno, R.E. Maloney, J.M. O'Donell, S.C. Roerig, and H.D. Battarbee Cardiac excitation-contraction coupling in the portal hypertensive rat Am J Physiol (Gastrointest) 279 2000 G28 G39
35. J.H. Henriksen, J.P. Götze, S. Fuglsang, E. Christensen, F. Bendtsen, and S. Møller Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease Gut 52 2003 1511 1517